-
1
-
-
0034676602
-
The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction
-
Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-1453.
-
(2000)
N Engl J Med
, vol.343
, pp. 1445-1453
-
-
Kim, R.J.1
Wu, E.2
Rafael, A.3
-
2
-
-
4143124289
-
Contrast-enhanced MR imaging of the heart: Overview of the literature
-
Edelman RR. Contrast-enhanced MR imaging of the heart: overview of the literature. Radiology. 2004;232:653-668.
-
(2004)
Radiology
, vol.232
, pp. 653-668
-
-
Edelman, R.R.1
-
3
-
-
4344707963
-
Influence of contrast agent dose and image acquisition timing on the quantitative determination of nonviable myocardial tissue using delayed contrast-enhanced magnetic resonance imaging
-
Petersen SE, Mohrs OK, Horstick G, et al. Influence of contrast agent dose and image acquisition timing on the quantitative determination of nonviable myocardial tissue using delayed contrast-enhanced magnetic resonance imaging. J Cardiovasc Magn Reson. 2004;6:541-548.
-
(2004)
J Cardiovasc Magn Reson
, vol.6
, pp. 541-548
-
-
Petersen, S.E.1
Mohrs, O.K.2
Horstick, G.3
-
4
-
-
0033539584
-
Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function
-
Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992-2202.
-
(1999)
Circulation
, vol.100
, pp. 1992-2202
-
-
Kim, R.J.1
Fieno, D.S.2
Parrish, T.B.3
-
5
-
-
34250025385
-
Gadolinium use in patients with kidney disease: A cause for concern
-
Perazella MA, Rodby RA. Gadolinium use in patients with kidney disease: a cause for concern. Semin Dial. 2007;20:179-185.
-
(2007)
Semin Dial
, vol.20
, pp. 179-185
-
-
Perazella, M.A.1
Rodby, R.A.2
-
6
-
-
34147193807
-
Nephrogenic systemic fibrosis: Risk factors and incidence estimation
-
Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology. 2007;243:148-157.
-
(2007)
Radiology
, vol.243
, pp. 148-157
-
-
Sadowski, E.A.1
Bennett, L.K.2
Chan, M.R.3
-
7
-
-
34548671875
-
Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: Retrospective study of a renal replacement therapy cohort
-
Collidge TA, Thomson PC, Mark PB, et al. Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort. Radiology. 2007;245:168-175.
-
(2007)
Radiology
, vol.245
, pp. 168-175
-
-
Collidge, T.A.1
Thomson, P.C.2
Mark, P.B.3
-
8
-
-
0031452736
-
Gadolinium chelates with weak binding to serum proteins
-
Cavagna FM, Maggioni F, Castelli PM, et al. Gadolinium chelates with weak binding to serum proteins. Invest Radiol. 1997;32:780-796.
-
(1997)
Invest Radiol
, vol.32
, pp. 780-796
-
-
Cavagna, F.M.1
Maggioni, F.2
Castelli, P.M.3
-
9
-
-
19944433022
-
Contrast-enhanced MR angiography of the renal arteries: Blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine
-
Prokop M, Schneider G, Vanzulli A, et al. Contrast-enhanced MR angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology. 2005;234:399-408.
-
(2005)
Radiology
, vol.234
, pp. 399-408
-
-
Prokop, M.1
Schneider, G.2
Vanzulli, A.3
-
10
-
-
0033851515
-
Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction
-
Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959-969.
-
(2000)
J Am Coll Cardiol
, vol.36
, pp. 959-969
-
-
Alpert, J.S.1
Thygesen, K.2
Antman, E.3
-
11
-
-
23844485892
-
Myocardial infarct: Depiction with contrast-enhanced MR imaging - comparison of gadopentetate and gadobenate
-
Schlosser T, Hunold P, Herborn CU, et al. Myocardial infarct: depiction with contrast-enhanced MR imaging - comparison of gadopentetate and gadobenate. Radiology. 2005;236:1041-1046.
-
(2005)
Radiology
, vol.236
, pp. 1041-1046
-
-
Schlosser, T.1
Hunold, P.2
Herborn, C.U.3
-
12
-
-
0037192118
-
Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart
-
Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. Circulation. 2002;105:539-542.
-
(2002)
Circulation
, vol.105
, pp. 539-542
-
-
Cerqueira, M.D.1
Weissman, N.J.2
Dilsizian, V.3
-
13
-
-
84908219488
-
Statistical methods for assessing agreement between two methods of clinical measurement
-
Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
-
(1986)
Lancet
, vol.1
, pp. 307-310
-
-
Bland, J.M.1
Altman, D.G.2
-
15
-
-
0017360990
-
The measurement of observer agreement for categorical data
-
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
-
(1977)
Biometrics
, vol.33
, pp. 159-174
-
-
Landis, J.R.1
Koch, G.G.2
-
16
-
-
0030066685
-
Assessment of acute myocardial infarction in man with magnetic resonance imaging and the use of a new paramagnetic contrast agent gadolinium-BOPTA
-
Holman ER, van Rossum AC, Doesburg T, et al. Assessment of acute myocardial infarction in man with magnetic resonance imaging and the use of a new paramagnetic contrast agent gadolinium-BOPTA. Magn Reson Imaging. 1996;14:21-29.
-
(1996)
Magn Reson Imaging
, vol.14
, pp. 21-29
-
-
Holman, E.R.1
van Rossum, A.C.2
Doesburg, T.3
-
17
-
-
0034757441
-
Comparison of gadobenate dimeglumine with gadopentetate dimeglumine for magnetic resonance imaging of liver tumor
-
Kuwatsuru R, Kadoya M, Ohtomo K, et al. Comparison of gadobenate dimeglumine with gadopentetate dimeglumine for magnetic resonance imaging of liver tumor. Invest Radiol. 2001;36:632-641.
-
(2001)
Invest Radiol
, vol.36
, pp. 632-641
-
-
Kuwatsuru, R.1
Kadoya, M.2
Ohtomo, K.3
-
18
-
-
23844529205
-
Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumors in children
-
Colosimo C, Demaerel P, Tortori-Donati P, et al. Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumors in children. Pediatr Radiol. 2005;35:501-510.
-
(2005)
Pediatr Radiol
, vol.35
, pp. 501-510
-
-
Colosimo, C.1
Demaerel, P.2
Tortori-Donati, P.3
-
19
-
-
33747619179
-
Delayed enhancement of subendocardial infracted myocardium with gadobenate dimeglumine: A paradoxical effect - is a double dose too much?
-
Sardanelli F, Quarenghi M. Delayed enhancement of subendocardial infracted myocardium with gadobenate dimeglumine: a paradoxical effect - is a double dose too much? Radiology. 2006;240:915.
-
(2006)
Radiology
, vol.240
, pp. 915
-
-
Sardanelli, F.1
Quarenghi, M.2
-
20
-
-
33744998674
-
Low-dose gadobenate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging
-
Balci NC, Inan N, Anik Y, et al. Low-dose gadobenate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging. Acad Radiol. 2006;13:833-839.
-
(2006)
Acad Radiol
, vol.13
, pp. 833-839
-
-
Balci, N.C.1
Inan, N.2
Anik, Y.3
-
21
-
-
0037145936
-
Positron emission tomography and recovery following revascularization (PARR-1): The importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function
-
Beanlands RS, Ruddy TD, deKemp RA, et al. Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol. 2000;40:1735-1743.
-
(2000)
J Am Coll Cardiol
, vol.40
, pp. 1735-1743
-
-
Beanlands, R.S.1
Ruddy, T.D.2
deKemp, R.A.3
-
22
-
-
33646914953
-
Diagnostic testing
-
Kim RJ. Diagnostic testing. J Am Coll Cardiol. 2006;47:D23-D27.
-
(2006)
J Am Coll Cardiol
, vol.47
-
-
Kim, R.J.1
-
23
-
-
33645289942
-
Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
-
Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006;21:1104-1108.
-
(2006)
Nephrol Dial Transplant
, vol.21
, pp. 1104-1108
-
-
Grobner, T.1
-
24
-
-
33846541879
-
Gadiodiamide-associated nephrogenic systemic fibrosis: Why radiologists should be concerned
-
Broome DR, Girguis MS, Baron PW, et al. Gadiodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol. 2007;188:586-592.
-
(2007)
AJR Am J Roentgenol
, vol.188
, pp. 586-592
-
-
Broome, D.R.1
Girguis, M.S.2
Baron, P.W.3
-
25
-
-
33646236076
-
Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement
-
Wagner A, Mahrholdt H, Thomson L, et al. Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement. J Am Coll Cardiol. 2006;47:2027-2033.
-
(2006)
J Am Coll Cardiol
, vol.47
, pp. 2027-2033
-
-
Wagner, A.1
Mahrholdt, H.2
Thomson, L.3
|